| scholarly article | Q13442814 |
| P50 | author | Marc Stegger | Q63649712 |
| P2093 | author name string | Robert Skov | |
| Mia Torpdahl | |||
| Andreas Petersen | |||
| Maria Sjölund-Karlsson | |||
| Gunnar Kahlmeter | |||
| Erika Matuschek | |||
| Jenny Åhman | |||
| P2860 | cites work | Plasmid-mediated quinolone resistance: a multifaceted threat | Q24645356 |
| Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test | Q33963543 | ||
| Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
| Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003. | Q35635699 | ||
| Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli | Q35879095 | ||
| qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin | Q37072053 | ||
| Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States | Q37190695 | ||
| Antimicrobial resistance in typhoidal and nontyphoidal salmonellae | Q37251632 | ||
| Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium | Q37320182 | ||
| In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards | Q38023251 | ||
| Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae | Q40556003 | ||
| Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment | Q40642659 | ||
| Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A. | Q43778993 | ||
| Molecular characterization of a multidrug-resistant strain of enteroinvasive Escherichia coli O164 isolated in Japan. | Q45267170 | ||
| Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark | Q46577820 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| The global burden of nontyphoidal Salmonella gastroenteritis | Q50050617 | ||
| Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation | Q50087466 | ||
| Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. | Q54439939 | ||
| Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations o | Q62635883 | ||
| WHO Expert Committee on Biological Standardization: twenty-eighth report | Q66902136 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella enterica | Q2264864 |
| pefloxacin | Q2601859 | ||
| P304 | page(s) | 3411-3417 | |
| P577 | publication date | 2015-08-19 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica | |
| P478 | volume | 53 |
| Q47350228 | Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi |
| Q47159827 | ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animals |
| Q43214932 | Evaluation of Surrogate Disk Tests for Detection of Ciprofloxacin and Levofloxacin Resistance in Clinical Isolates of Salmonella enterica |
| Q36173899 | Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected]. |
| Q37298644 | IncHI2 Plasmids Are Predominant in Antibiotic-Resistant Salmonella Isolates |
| Q50027512 | MIC-based dose adjustment: facts and fables |
| Q40764604 | Molecular Characterization of Intermediate Susceptible Typhoidal Salmonella to Ciprofloxacin, and its Impact |
| Q38632309 | National Antimicrobial Resistance Monitoring System: Two Decades of Advancing Public Health Through Integrated Surveillance of Antimicrobial Resistance |
| Q41928922 | Pefloxacin as a surrogate marker for quinolone susceptibility in Salmonella enterica serovars Typhi & Paratyphi A in India |
| Q92865986 | Phenotypic screening for quinolone resistance in Escherichia coli |
| Q47157631 | The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014 |
| Q47158818 | The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015 |
| Q97071024 | The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016 |
| Q97072646 | The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017 |
Search more.